Executive Search Success Story: Building a Global R&D Team for a Pharmaceutical Manufacturer

How JRG Partners executed a confidential, multi-role executive retained search strategy that equipped a global pharmaceutical manufacturer with the critical scientific, drug discovery, and clinical development leadership required to accelerate pipeline development, expand innovation capacity, and improve collaboration across research and commercial functions.

The Challenge

A global pharmaceutical manufacturer was aggressively expanding its research operations across diverse therapeutic markets. To safely navigate this expansion, maximize research productivity, and establish seamless alignment across separate regional networks, the enterprise needed to reconstruct its international clinical development and core scientific leadership teams. Leadership identified several critical operational and market pressures:

• An acute shortage of experienced, high-impact pharmaceutical R&D executives globally
• Growing strategic demand for product innovation in highly competitive therapeutic markets
• Increasing scientific and operational complexity of international clinical development programs
• An immediate strategic need to improve collaboration across research and commercial business functions
• Unaddressed succession concerns among foundational senior scientific and core leadership positions
• Intense market pressure to accelerate pipeline development and commercialization timelines

The enterprise determined that stabilizing its scaling operations required a synchronized corporate management structure spanning a Head of Global Research & Development, Chief Scientific Officer, VP Drug Discovery, VP Global Clinical Development, VP Regulatory Strategy, VP Pharmaceutical Sciences, therapeutic area leaders, and research operations executives. Successfully executing this multi-role mandate required an executive search partner combining specialized global sourcing literacy with a track record of identifying data-driven scientific talent across primary innovation corridors.

Why They Chose JRG Partners

Deep Global Pharmaceutical R&D Specialization

Unlike generalist recruiting agencies that lack functional immersion in highly complex pre-clinical modeling, molecular discovery, and formulation development, JRG Partners maintains dedicated search practices spanning global drug discovery, clinical development, pharmaceutical sciences, and regulatory strategy. Our consultants carry a detailed operational understanding of both international compliance pipelines and specialized commercial acceleration parameters.

Real Access to Passive Talent

The most capable global research directors, clinical operators, and discovery innovators are typically fully integrated into high-performing corporate or academic frameworks, meaning they rarely monitor traditional job listings. JRG Partners bypassed conventional recruitment channels entirely, leveraging long-standing sector relationships, proprietary market intelligence, and executive networks to directly engage high-performing passive leaders invisible to standard sourcing methods.

Confidential Search Execution

Because this leadership architecture was built during an active global pipeline development phase where proprietary source formulations and market valuation metrics were at stake, absolute discretion was mandatory. JRG Partners deployed a highly secure, confidential vetting and outreach framework that successfully insulated the client’s strategic positioning, protected ongoing developmental programs, and maintained total candidate trust throughout the recruitment lifecycle.

True Global Sourcing Reach

Sourcing specialized clinical development and drug discovery executives capable of driving standardized performance across global pipelines required an outreach strategy unconstrained by geographic boundaries. JRG Partners executed a coordinated talent acquisition strategy targeting top-performing leaders from pharmaceutical companies, biotechnology organizations, specialty therapeutics developers, academic research institutions, clinical research organizations, and public life sciences companies across North America, Europe, and Asia.

Our Corporate Search Strategy

Phase 1 — Strategic Alignment & Leadership Assessment

Our consultants partnered directly with the board of directors and corporate executive team to map existing structural gaps, identify hidden succession risks, clarify capacity milestones, and define the exact leadership competencies required for long-term clinical and market integration. Rather than matching candidates against legacy job descriptions, we built forward-looking executive profiles dynamically tied to the enterprise’s long-term developmental strategy.

Phase 2 — Multi-Sector Market Mapping

JRG Partners executed an exhaustive market-mapping initiative targeting process-driven software, hardware, and chemical discovery environments globally. Our comprehensive market map targeted key talent pools across global pharmaceutical companies, biotechnology organizations, specialty therapeutics developers, academic research institutions, clinical research organizations, and public life sciences enterprises.

Phase 3 — Targeted Executive Engagement

Using a research-driven, highly discreet outreach framework, our consultants directly contacted and evaluated high-achieving corporate leaders with verified records of success in driving global pipeline advancement. Only candidates demonstrating clear, measurable operational impact and rigorous commercial fluency advanced to the final evaluation round.

Phase 4 — Rigorous Assessment & Final Selection

Each finalist candidate underwent an extensive evaluation process looking far beyond basic professional credentials. Our consultants conversion-tested strategic and functional capabilities, discovery platform agility, team-building and leadership philosophies, multi-jurisdictional compliance fluency, and long-term retention potential.

Key Outcomes

• 500+ senior corporate clinical development, drug discovery, and research operations hybrid executive profiles systematically mapped across major North American, European, and Asian life sciences innovation hubs.
• Successfully placed and integrated a complete executive leadership framework—spanning the Head of Global R&D, Chief Scientific Officer, and multiple vice presidents—within a tight 12-month timeline through a targeted retained search.
• Unified separate discovery, pharmaceutical sciences, and clinical operations assets under a single, cohesive corporate development strategy by installing process-driven pharmaceutical research leaders.
• Accelerated new-platform laboratory validation and standardized product lifecycles by placing forward-thinking global clinical development and regulatory strategy executives.
• Mitigated long-term operational risks and optimized multi-region developmental deployment frequency by placing specialized, data-driven drug discovery and research operations leaders.
• Protected crucial design pipelines, sensitive source architectures, and trial validation data during high-stakes growth phases through strict search confidentiality.
• Provided board directors and corporate stakeholders with a high-performance management framework explicitly equipped to eliminate regulatory barriers and drive profitable technical innovation at scale.